WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia

Tohoku Journal of Experimental Medicine

Volumn 219, Issue 2, 2009, Pages 169-176

  Sakamoto, Yuichi ^a   Mariya, Yasushi ^a   Sasaki, Sumiko ^a   Teshiromori, Ryuichi ^a   Oshikiri, Toshiyuki ^a   Segawa, Megumi ^a   Ogura, Kazuto ^a   Akagi, Tomoaki ^a   Kubo, Koumei ^a   Kaimori, Mitsuomi ^a   Funato, Tadao ^b  

^a AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b TOHOKU FUKUSHI UNIVERSITY   (Japan)

Author keywords

Acute leukemia; Hematopoietic stem cell transplantation; Minimal residual disease; Real time quantitative PCR; Wilms' tumor gene 1

Indexed keywords

ACLARUBICIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MESSENGER RNA; METHOTREXATE; TACROLIMUS; VINCRISTINE; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC VALUE; FEMALE; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA CELL; LEUKOPENIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PROSTATE CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT CANCER; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM, RESIDUAL; RECURRENCE; REMISSION INDUCTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 70449669328     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.219.169     Document Type: Article

References (26)

1. Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., Jones, C. & Housman, D.E. (1992) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520.
2. Campbell, C.E., Kuriyan, N.P., Rackley, R.R., Caulfield, M.J., Tubbs, R., Finke, J. & Williams, B.R. (1998) Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int. J. Cancer, 78, 182-188.
3. Candoni, A., Tiribelli, M., Toffoletti, E., Cilloni, D., Chiarvesio, A., Michelutti, A., Simeone, E., Pipan, C., Saglio, G. & Fanin, R. (2008) Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. Eur. J. Haematol., 82, 61-68.
4. Cilloni, D., Gottardi, E., De Micheli, D., Serra, A., Volpe, G., Messa, F., Rege-Cambrin, G., Guerrasio, A., Divona, M., Lo Coco, F. & Saglio, G. (2002) Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia, 16, 2115-2121.
5. Cilloni, D., Gottardi, E., Fava, M., Messa, F., Carturan, S., Busca, A., Guerrasio, A. & Saglio, G. (2003) Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection. Blood, 102, 773-774. (Pubitemid 36842006)
6. Cilloni, D., Messa, F., Arruga, F., Defilippi, I., Gottardi, E., Fava, M., Carturan, S., Catalano, R., Bracco, E., Messa, E., Nicoli, P., Diverio, D., Sanz, M.A., Martinelli, G., Lo-Coco, F. & Saglio, G. (2008) Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy. Haematologica, 93, 921-924.
7. Cilloni, D. & Saglio, G. (2004) WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome. Acta Haematol., 112, 79-84. (Pubitemid 38716252)
8. Elmaagacli, A.H., Beelen, D.W., Trenschel, R. & Schaefer, U.W. (2000) The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow transplantation or peripheral blood stem cell transplantation. Bone Marrow Transplant., 25, 91-96. (Pubitemid 30093162)
9. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T. & Sugiyama, H. (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89, 1405-1412. (Pubitemid 27080005)
10. Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., Hiraoka, A., Masaoka, T., Kishimoto, T. & Sugiyama, H. (1996) Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood, 88, 2267-2278. (Pubitemid 26307931)
11. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T. & Nasu, K. (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079. (Pubitemid 24328100)
12. Kern, W., Haferlach, C., Haferlach, T. & Schnittger, S. (2008) Monitoring of minimal residual disease in acute myeloid leukemia. Cancer, 112, 4-16.
13. Lapillonne, H., Renneville, A., Auvrignon, A., Flamant, C., Blaise, A., Perot, C., Lai, J.L., Ballerini, P., Mazingue, F., Fasola, S., Dehée, A., Bellman, F., Adam, M., Labopin, M., Douay, L., Leverger, G., Preudhomme, C. & Landman-Parker, J. (2006) High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. J. Clin. Oncol., 24, 1507-1515.
14. Miwa, H., Beran, M. & Saunders, G.F. (1992) Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia, 6, 405-409.
15. Miyoshi, Y., Ando, A., Egawa, C., Taguchi, T., Tamaki, Y., Tamaki, H., Sugiyama, H. & Noguchi, S. (2002) High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin. Cancer Res., 8, 1167-1171.
16. Mizuta, S., Ito, Y., Kohno, A., Kiyoi, H., Miyamura, K., Tanimoto, M., Takamatsu, J., Naoe, T., Morishima, Y., Ueda, R. & Saito, H. (1999) Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group. Bone Marrow Transplant., 24, 777-784.
17. Neale, G.A., Coustan-Smith, E., Stow, P., Pan, Q., Chen, X., Pui, C.H. & Campana, D. (2004) Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 18, 934-938.
18. Nyvold, C.G., Stentoft, J., Braendstrup, K., Melsvik, D., Moestrup, S.K., Juhl-Christensen, C., Hasle, H. & Hokland, P. (2006) Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia, 20, 2051-2054. (Pubitemid 44614901)
19. Ogawa, H., Tamaki, H., Ikegame, K., Soma, T., Kawakami, M., Tsuboi, A., Kim, E.H., Hosen, N., Murakami, M., Fujioka, T., Masuda, T., Taniguchi, Y., Nishida, S., Oji, Y., Oka, Y. & Sugiyama, H. (2003) The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood, 101, 1698-1704.
20. Ogawa, H., Tsuboi, A., Oji, Y., Tamaki, H., Soma, T., Inoue, K. & Sugiyama, H. (1998) Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of monitoring of minimal residual disease by WT1 assay. Bone Marrow Transplant., 21, 525-527. (Pubitemid 28107962)
21. Ommen, H.B., Nyvold, G.C., Breaendstrup, K., Andersen, B.L., Ommen, I.B., Hasle, H., Hokland, P. & Østergaard, M. (2008) Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: developement of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals. Br. J. Haematol., 141, 782-791.
22. Sotobori, T., Ueda, T., Oji, Y., Naka, N., Araki, N., Myoui, A., Sugiyama, H. & Yoshikawa, H. (2006) Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma. Cancer, 106, 2233-2240. (Pubitemid 43673246)
23. Trka, J., Kalinová, M., Hrusák, O., Zuna, J., Krejcí, O., Madzo, J., Sedlácek, P., Vávra, V., Michalová, K., Jarosová, M., Stary, J.; For Czech Paediatric Haematology Working Group. (2002) Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia, 16, 1381-1389.
24. Ueda, T., Oji, Y., Naka, N., Nakano, Y., Takahashi, E., Koga, S., Asada, M., Ikeba, A., Nakatsuka, S., Abeno, S., Hosen, N., Tomita, Y., Aozasa, K., Tamai, N., Myoui, A., Yoshikawa, H. & Sugiyama, H. (2003) Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci., 94, 271-276. (Pubitemid 36575894)
25. van der Velden, V.H., Boeckx, N., Gonzalez, M., Malec, M., Barbany, G., Lion, T., Gottardi, E., Pallisgaard, N., Beillard, E., Hop, W.C., Hoogeveen, P.G., Gabert, J., van Dongen, J.J.; Europe Against Cancer Program. (2004) Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - a study within the Europe Against Cancer Program. Leukemia, 18, 884-886.
26. Weisser, M., Kern, W., Rauhut, S., Schoch, C., Hiddemann, W., Haferlach, T. & Schnittger, S. (2005) Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukaemia. Leukemia, 19, 1416-1423. (Pubitemid 41148947)